Acessibilidade / Reportar erro

Increasing trend of sensitization to Methylchloroisothiazolinone/methylisothiazolinone (MCI/MI)* * Work performed at the Ambulatório de Dermatologia do Hospital das Clínicas da Universidade Federal de Minas Gerais (UFMG) - Belo Horizonte (MG), Brazil.

Recent reports have shown increased sensitization to Methylchloroisothiazolinone/methylisothiazolinone. We report a retrospective study conducted at the Hospital das Clínicas - UFMG, based on the results of patch tests with the Brazilian standard series, performed on referred patients. The positive results in 359 patients from November 2009 to October 2012 were analyzed and compared with the previous data collected from March 2006 to October 2009 (447 patients). The data showed 11.14% sensitization to Methylchloroisothiazolinone/ methylisothiazolinone during 2009-2012, contrasting with the previous period (3.35%). A positive association was found between its positivity and the period of 2009-2012.

Dermatitis, allergic contact; Epidemiology; Preservatives, pharmaceutical


Sociedade Brasileira de Dermatologia Av. Rio Branco, 39 18. and., 20090-003 Rio de Janeiro RJ, Tel./Fax: +55 21 2253-6747 - Rio de Janeiro - RJ - Brazil
E-mail: revista@sbd.org.br